Recent News

• 08.25.2025 - Enliven Therapeutics Announces Oral and Poster Presentations at the Society of Hematologic Oncology (SOHO) 2025 Annual Meeting
• 08.25.2025 - Enliven Therapeutics Announces Oral and Poster Presentations at the Society of Hematologic Oncology (SOHO) 2025 Annual Meeting
• 08.13.2025 - Enliven Therapeutics Reports Second Quarter Financial Results and Provides a Business Update
• 08.13.2025 - Enliven Therapeutics Reports Second Quarter Financial Results and Provides a Business Update

Recent Filings

• 08.21.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.21.2025 - 4/A Statement of changes in beneficial ownership of securities
• 08.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.19.2025 - 144 Report of proposed sale of securities
• 08.18.2025 - 144 Report of proposed sale of securities
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.14.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.13.2025 - 8-K Current report
• 08.13.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]